| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1460-9568.2001.01363.X |
| P698 | PubMed publication ID | 11135013 |
| P2093 | author name string | R Maldonado | |
| B L Kieffer | |||
| H W Matthes | |||
| J Garzón | |||
| M Rodríguez-Díaz | |||
| P Sánchez-Blázquez | |||
| D M Hutcheson | |||
| E Valjent | |||
| P2860 | cites work | Opioids: first lessons from knockout mice | Q33547877 |
| Molecular and cellular basis of addiction | Q34440561 | ||
| Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse | Q35874052 | ||
| Development of delta opioid peptides as nonaddicting analgesics | Q37170275 | ||
| Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression | Q37895578 | ||
| delta-Opioid receptor subtypes and cross-talk with mu-receptors | Q40853754 | ||
| Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides | Q41041826 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal | Q42551590 | ||
| Morphine withdrawal in cortical slices: suppression by Ca2+-channel inhibitors of abstinence-induced [3H]-noradrenaline release | Q42849334 | ||
| Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats | Q43192342 | ||
| The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study | Q43695146 | ||
| delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice | Q44330291 | ||
| Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice | Q44330314 | ||
| Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist | Q44331570 | ||
| Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists | Q44332157 | ||
| Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered μ-opioid receptor agonist in the mouse | Q44333480 | ||
| Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. | Q44336761 | ||
| Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance | Q44337011 | ||
| Differences in physical dependence induced by selective mu or delta opioid agonists and by endogenous enkephalins protected by peptidase inhibitors | Q44338459 | ||
| Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in mice | Q44342892 | ||
| Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by delta opioid receptor subtypes in mice | Q44344945 | ||
| The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia | Q44345741 | ||
| Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts | Q44345799 | ||
| In vivo evidence for the selectivity of ICI 154129 for the delta-opioid receptor | Q44345918 | ||
| Dimerization of the delta opioid receptor: implication for a role in receptor internalization | Q44347088 | ||
| Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene | Q44347879 | ||
| Mu and delta receptors: Their role in analgesia and in the differential effects of opioid peptides on analgesia | Q44353058 | ||
| Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes | Q48171483 | ||
| Transport of CSF antibodies to Galpha subunits across neural membranes requires binding to the target protein and protein kinase C activity. | Q48270983 | ||
| Concurrent nimodipine attenuates the withdrawal signs and the increase of cerebral dihydropyridine binding after chronic morphine treatment in rats | Q48296641 | ||
| Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain | Q48745950 | ||
| Naloxone-precipitated withdrawal in morphine-dependent rats increases the expression of alpha 2a-adrenoceptor mRNA in brain | Q48747696 | ||
| Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. | Q48944677 | ||
| Chronic inhibition of intracellular Ca2+ release or protein kinase C activation significantly reduces the development of morphine dependence | Q49010576 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 153-161 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice | |
| P478 | volume | 13 |
| Q38092089 | Advancing addiction treatment: what can we learn from animal studies? |
| Q44251956 | Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. |
| Q41980424 | Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors |
| Q46660426 | Genetics of Tobacco Use. |
| Q37164984 | Genetics of tobacco use. |
| Q36775271 | Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the δ opioid receptor |
| Q42067858 | In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential |
| Q37062556 | Molecular Pharmacology of δ-Opioid Receptors |
| Q34012381 | Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system |
| Q28111990 | Nicotine and endogenous opioids: Neurochemical and pharmacological evidence |
| Q39998920 | Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling |
| Q36296493 | Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior |
| Q42325921 | The endogenous opioid system and drug addiction |
Search more.